Direkt zum Inhalt
Merck

Adverse drug reactions induced by valproic acid.

Clinical biochemistry (2013-06-25)
Radu M Nanau, Manuela G Neuman
ZUSAMMENFASSUNG

Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic profiles, as well as a relatively favorable safety profile. However, adverse drug reactions have been reported in relation with valproic acid use, either as monotherapy or polytherapy with other antiepileptic drugs or antipsychotic drugs. This systematic review discusses valproic acid adverse drug reactions, in terms of hepatotoxicity, mitochondrial toxicity, hyperammonemic encephalopathy, hypersensitivity syndrome reactions, neurological toxicity, metabolic and endocrine adverse events, and teratogenicity.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

USP
Valproinsäure, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
2-Propylpentansäure
Supelco
Valproic acid solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Valproinsäure, Pharmaceutical Secondary Standard; Certified Reference Material
Valproinsäure, European Pharmacopoeia (EP) Reference Standard